BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Nov 26, 2025; 17(11): 107637
Published online Nov 26, 2025. doi: 10.4330/wjc.v17.i11.107637
Cardiac sarcoidosis: The role of steroid therapy in managing myocardial inflammation and arrhythmic risks
Simran Bhimani, Chaitanya Rojulpote, Yash Deshpande, Anand Reddy Maligireddy
Simran Bhimani, Internal Medicine, The Wright Center for Graduate Medical Education, Scranton, PA 18505, United States
Chaitanya Rojulpote, Department of Cardiology, Saint Louis University, St. Louis, MO 63103, United States
Yash Deshpande, Anand Reddy Maligireddy, Department of Medicine, The Wright Center for Graduate Medical Education, Scranton, PA 18505, United States
Author contributions: Bhimani S, Rojulpote C, Deshpande Y, and Maligireddy AR conceptualized and designed the manuscript; Bhimani S and Deshpande Y drafted the initial sections; Rojulpote C contributed to the literature synthesis; Maligireddy AR critically revised the manuscript and coordinated final edits; all authors reviewed and approved the final version.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Anand Reddy Maligireddy, MD, Department of Medicine, The Wright Center for Graduate Medical Education, Washington Avenue, Scranton, PA 18505, United States. drmaligireddy@gmail.com
Received: March 28, 2025
Revised: May 15, 2025
Accepted: October 22, 2025
Published online: November 26, 2025
Processing time: 238 Days and 14.5 Hours
Core Tip

Core Tip: Cardiac sarcoidosis is a potentially life-threatening condition characterized by granulomatous inflammation of the myocardium, leading to conduction abnormalities, heart failure, and arrhythmias. This review highlights the central role of corticosteroid therapy in controlling myocardial inflammation and improving cardiac function. It also underscores the limitations of long-term steroid use and the importance of advanced imaging-such as cardiac magnetic resonance imaging and positron emission tomography-in guiding diagnosis, treatment, and arrhythmic risk stratification. A multidisciplinary approach, including immunosuppressive therapy and implantable cardioverter-defibrillator placement, is essential for optimal patient outcomes.